Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_2
4
44%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
4(50.0%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
unknown2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (50.0%)
Phase 31 (12.5%)
N/A3 (37.5%)

Trials by Status

completed556%
unknown222%
withdrawn222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9